GRDN Guardian Pharmacy Services, Inc.

NYSE
$48.84

Guardian Pharmacy Services, Inc. (GRDN) is expected to report earnings on February 4, 2027, after the market close. The consensus earnings estimate is $0.42 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +12.5% since its last earnings release on November 5, 2026.

Guardian Pharmacy Services Beat Consensus Estimates, Raises Guidance In-line with Estimates
Thursday, November 5, 2026 · 4:05 PM ET
Earnings Date
4th Quarter, Dec 2026
Feb 4
Thursday · 4:05 PM ET
Earnings Whisper
-
vs $0.42
Rev est $388.81M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $47.87

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Guardian Pharmacy Services, Inc.

Guardian Pharmacy Services is a leading long-term care pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of long-term health care facilities (“LTCFs”) adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes.

Sector

Healthcare

Industry

Specialized Health Services

Held By 1 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.